Clinical Trials in Nashville

Showing 41-60 of 15,379 trials

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors

NCT05636618

This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Neuroendocrine Tumors UnresectableNeuroendocrine Tumor MetastaticGastroenteropancreatic Neuroendocrine Tumor+3 more

Perspective Therapeutics260 participantsStarted Sep 2023

Jacksonville, Florida, United States • Miami, Florida, United States • Chicago, Illinois, United States +14 more locations

RECRUITINGPhase 1/2< 1 mile

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.

CancerColorectal CancerSolid Tumor+12 more

Parabilis Medicines, Inc.595 participantsStarted May 2023

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +22 more locations

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Find Trials by Condition in Nashville

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Study for AZD4360 in Participants With Advanced Solid Tumours

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System